Publications

ChAdOx1 nCoV-19 (AZD1222) or nCoV-19-Beta (AZD2816) protect Syrian hamsters against Beta Delta and Omicron variants.

van Doremalen N. et al, (2022), Nature communications, 13

Omicron-associated changes in SARS-CoV-2 symptoms in the United Kingdom.

Vihta KD. et al, (2022), Clin Infect Dis

Mucosal-Associated Invariant T cells exhibit distinct functional signatures associated with protection against typhoid fever

Salerno-Gonçalves R. et al, (2022), Cellular Immunology, 378

ISARIC-COVID-19 dataset: A Prospective, Standardized, Global Dataset of Patients Hospitalized with COVID-19.

ISARIC Clinical Characterization Group None. et al, (2022), Scientific data, 9

Severe acute hepatitis of unknown aetiology in children-what is known?

Khader S. et al, (2022), BMC medicine, 20

SARS-CoV-2 lineage dynamics in England from September to November 2021: high diversity of Delta sub-lineages and increased transmissibility of AY.4.2.

Eales O. et al, (2022), BMC infectious diseases, 22

Correction to: MAIT cells in liver inflammation and fibrosis.

Mehta H. et al, (2022), Seminars in immunopathology

Optimising Exome Prenatal Sequencing Services (EXPRESS): a study protocol to evaluate rapid prenatal exome sequencing in the NHS Genomic Medicine Service

Hill M. et al, (2022), NIHR Open Research, 2, 10 - 10

Scholarly Publishing, Boundary Processes, and the Problem of Fake Peer Reviews

Bell K. et al, (2022), SCIENCE TECHNOLOGY & HUMAN VALUES

Moving from Collaboration to Co-production in International Research

Heath C. and Mormina M., (2022), The European Journal of Development Research

SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway.

Willett BJ. et al, (2022), Nature microbiology

Prevalence and risk factors of post-COVID-19 condition in adults and children at 6 and 12 months after hospital discharge: a prospective, cohort study in Moscow (StopCOVID).

Pazukhina E. et al, (2022), BMC medicine, 20

A prototype lateral flow assay for detection of orthopoxviruses.

Ulaeto DO. et al, (2022), The Lancet. Infectious diseases

Addressing vaccine inequities among Ukrainian refugees.

Hill M. et al, (2022), Lancet Infect Dis, 22, 935 - 936

Assessment of an institutional guideline for vancomycin dosing and identification of predictive factors associated with dose and drug trough levels

Gu Q. et al, (2022), Journal of Infection

Effect of childhood vaccination and antibiotic use on pneumococcal populations and genome-wide associations with disease among children in Nepal: an observational study.

Kandasamy R. et al, (2022), The Lancet. Microbe, 3, e503 - e511

Long COVID: aiming for a consensus.

Munblit D. et al, (2022), The Lancet. Respiratory medicine, 10, 632 - 634

M. tuberculosis microvariation is common and is associated with transmission: Analysis of three years prospective universal sequencing in England

Wyllie D. et al, (2022), Journal of Infection, 85, 31 - 39

Systematic review of host genomic biomarkers of invasive bacterial disease: Distinguishing bacterial from non-bacterial causes of acute febrile illness.

Kelly E. et al, (2022), EBioMedicine, 81

Year-to-year variation in attack rates could result in underpowered respiratory syncytial virus vaccine efficacy trials

Billard MN. et al, (2022), Journal of Clinical Epidemiology, 147, 11 - 20

Symptom-based case definitions for COVID-19: time and geographical variations for detection at hospital admission among 260,000 patients

Group ISARICCC. et al, (2022)

An exploratory analysis of the response to ChAdOx1 nCoV-19 (AZD1222) vaccine in males and females.

Marchevsky NG. et al, (2022), EBioMedicine, 81

SARS-CoV-2 antibody trajectories after a single COVID-19 vaccination with and without prior infection.

Wei J. et al, (2022), Nat Commun, 13

Experiences of and response to the COVID-19 pandemic at private retail pharmacies in Kenya: a mixed-methods study.

Mugo PM. et al, (2022), BMJ open, 12

Structural Analysis and Development of Notum Fragment Screening Hits.

Zhao Y. et al, (2022), ACS chemical neuroscience

Chest CT and Hospital Outcomes in Patients with Omicron Compared with Delta Variant SARS-CoV-2 Infection.

Tsakok MT. et al, (2022), Radiology

Mortality risks associated with empirical antibiotic activity in Escherichia coli bacteraemia: an analysis of electronic health records.

Yoon CH. et al, (2022), J Antimicrob Chemother

A core outcome set for post-COVID-19 condition in adults for use in clinical practice and research: an international Delphi consensus study.

Munblit D. et al, (2022), The Lancet. Respiratory medicine

Availability, scope, and quality of monkeypox clinical management guidelines globally: a systematic review

Webb E. et al, (2022)

Primary and secondary functions of HLA-E are determined by stability and conformation of the peptide-bound complexes

Walters LC. et al, (2022), Cell Reports, 39

Vaccines based on the replication-deficient simian adenoviral vector ChAdOx1: Standardized template with key considerations for a risk/benefit assessment.

Folegatti PM. et al, (2022), Vaccine

Inclusion of a dual signal sequence enhances the immunogenicity of a novel viral vectored vaccine against the capsular group B meningococcus.

Sheerin D. et al, (2022), Cell & bioscience, 12

Immunogenicity of a single 4CMenB vaccine booster in adolescents 11 years after childhood immunisation.

Rollier CS. et al, (2022), Vaccine

Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serum.

Tuekprakhon A. et al, (2022), Cell

Primary motivations for and experiences with paediatric minimally invasive tissue sampling (MITS) participation in Malawi: a qualitative study.

Lawrence S. et al, (2022), BMJ open, 12

Catwalk: identifying closely related sequences in large microbial sequence databases.

Volk D. et al, (2022), Microbial genomics, 8

Europe-wide expansion and eradication of multidrug-resistant Neisseria gonorrhoeae lineages: a genomic surveillance study.

Sánchez-Busó L. et al, (2022), Lancet Microbe, 3, e452 - e463

Experience of Kenyan researchers and policy-makers with knowledge translation during COVID-19: a qualitative interview study.

Guleid FH. et al, (2022), BMJ open, 12

Impact of a blood-stage vaccine on Plasmodium vivax malaria

Hou MM. et al, (2022)

Mycobacterium tuberculosis transmission in Birmingham, UK, 2009–19: An observational study

Walker TM. et al, (2022), The Lancet Regional Health - Europe, 17, 100361 - 100361

Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: Three month analyses of the COV-BOOST trial.

Liu X. et al, (2022), The Journal of infection, 84, 795 - 813

Post-COVID-19 condition in children: a COS is urgently needed

Munblit D. et al, (2022), The Lancet Respiratory Medicine

Potent cross-reactive antibodies following Omicron breakthrough in vaccinees.

Nutalai R. et al, (2022), Cell, 185, 2116 - 2131.e18

Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine in children aged 6-17 years: a preliminary report of COV006, a phase 2 single-blind, randomised, controlled trial.

Li G. et al, (2022), Lancet (London, England), 399, 2212 - 2225

Whole genome sequencing reveals hidden transmission of carbapenemase-producing Enterobacterales.

Marimuthu K. et al, (2022), Nature communications, 13

MAIT cells in liver inflammation and fibrosis.

Mehta H. et al, (2022), Seminars in immunopathology

Defining the key intrahepatic gene networks in HCV infection driven by sex.

Marchi E. et al, (2022), Gut

Waking up to monkeypox.

Nakoune E. and Olliaro P., (2022), BMJ (Clinical research ed.), 377

Fatal COVID-19 outcomes are associated with an antibody response targeting epitopes shared with endemic coronaviruses.

McNaughton AL. et al, (2022), JCI insight

Viral vector vaccines.

McCann N. et al, (2022), Current opinion in immunology, 77

Cookies on this website

Publications